Pharmaceutical News

RSS

Scientists explore biomedical applications in implants, drug delivery for hydrogel

It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.

6 Jul 2013

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

An Ontario-wide research network based at St. Michael's Hospital has received a three-year, $4.7 million grant from the province of Ontario to conduct policy-driven prescription drug research.

6 Jul 2013

New study could lead to better and more targeted drugs for arthritis and cancer

The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new international study co-authored by researchers at Imperial College London.

5 Jul 2013

Researchers develop new tool to promote improved drug development

Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell.

5 Jul 2013

Oncologist urges drug companies to include key information in cancer drug labels

In the July 10th issue of The New England Journal of Medicine, Dr. Basch calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.

5 Jul 2013

Duke researchers solve some mysteries related to the use of aspirin

Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why some people benefit and others don't.

4 Jul 2013

Gerovital H3 may be making a comeback, warns BUSM researcher

Despite it being more than 30 years since the "fountain of youth drug" Gerovital H3 was banned in the United States, it may be making a comeback. In an editorial published in this month's Journal of the American Geriatrics Society BUSM researcher Thomas Perls, MD, points out that a few U.S.-based anti-aging and longevity clinics have begun to advertise Gerovital H3 in pill form and as intravenous infusions despite the fact that the U.S. Food and Drug Administration banned it in 1982.

4 Jul 2013

Employers worry they'll pay bill for those exempt from contraceptive mandate

Businesses are concerned that non-religious employers will end up covering the bill for religious groups that refuse to pay for contraception for their employees. Meanwhile, church leaders continue their push to broaden the exemption from the contraception coverage rule.

4 Jul 2013

GAPVAC aims to develop personalized therapeutic vaccines for cancer

A highly innovative project supported by a €6 million European Union Framework 7 (EU FP7) program grant to develop a novel class of therapeutic cancer vaccines is now under way.

4 Jul 2013

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Orexo today announced that it has received approval from the U.S. Food and Drug Administration for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.

4 Jul 2013

Research shows lower daily dose of HIV drug therapy suppresses virus

Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).

4 Jul 2013

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

A team of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University has discovered why long-term treatment with many common antibiotics can cause harmful side effects-and they have uncovered two easy strategies that could help prevent these dangerous responses.

4 Jul 2013

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law - one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Genentech's obinutuzumab gets FDA Priority Review for chronic lymphocytic leukemia

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for obinutuzumab (GA101) and granted Priority Review for GA101 in the treatment of chronic lymphocytic leukemia, one of the most common forms of blood cancer, based on final Stage 1 data from the pivotal CLL11 trial.

3 Jul 2013

Data on side effects of fidaxomicin not analysed appropriately

The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile.

3 Jul 2013

Key HIV drug prices continue to fall, but newer medicines still priced too high

International medical humanitarian organisation Médecins Sans Frontières today released its annual report Untangling the Web of ARV Price Reductions,at the International AIDS Society conference in Kuala Lumpur.

3 Jul 2013

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Scientists found genetic variations that could be used to identify women who are most likely to benefit from a certain type of breast cancer prevention drug—and who should avoid it.

3 Jul 2013

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023, according to a study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

3 Jul 2013

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated.

3 Jul 2013

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

A chemical component present in the nightshade family of plants is one of the world's most tenaciously addictive substances. It is the nicotine contained in tobacco and found in high concentrations in cigarettes. Smoking remains a global scourge; in the U.S. it is the leading source of preventable death.

3 Jul 2013

Pharmaceutical News

Scientists explore biomedical applications in implants, drug delivery for hydrogel

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

New study could lead to better and more targeted drugs for arthritis and cancer

Researchers develop new tool to promote improved drug development

Oncologist urges drug companies to include key information in cancer drug labels

Duke researchers solve some mysteries related to the use of aspirin

Gerovital H3 may be making a comeback, warns BUSM researcher

Employers worry they'll pay bill for those exempt from contraceptive mandate

GAPVAC aims to develop personalized therapeutic vaccines for cancer

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Research shows lower daily dose of HIV drug therapy suppresses virus

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Genentech's obinutuzumab gets FDA Priority Review for chronic lymphocytic leukemia

Data on side effects of fidaxomicin not analysed appropriately

Key HIV drug prices continue to fall, but newer medicines still priced too high

Genetic variations can identify women who are likely to benefit from breast cancer prevention drug

Two-dimensional barcodes on vaccine improve safety of the U.S. immunization system, save millions

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News